| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 77,658 | 63,838 | 55,806 | 44,189 | | Cost of Revenue | 70,092 | 62,628 | 55,122 | 42,159 | | | Gross Profit | 7,566 | 1,210 | 684 | 2,030 | | | Operating Expenses | | Research Development | 4,417 | 4,444 | 4,446 | 5,668 | | Selling General and Administrative | 56,393 | 6,742 | 6,376 | 6,808 | | Non Recurring | (47,251) | 1,512 | 49,133 | 40,843 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,993) | (11,488) | (59,271) | (51,289) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,596 | 3,022 | 1,514 | (26) | | Earnings Before Interest And Taxes | (22,739) | (7,314) | (58,909) | (49,104) | | Interest Expense | 7,430 | 6,532 | 5,380 | 3,034 | | Income Before Tax | (10,827) | (13,846) | (64,289) | (52,138) | | Income Tax Expense | (7,805) |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (82,445) | (20,338) | (64,289) | (52,138) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (82,445) | (20,338) | (64,289) | (52,138) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($82,445) | ($20,338) | ($64,289) | ($52,138) |
|
0.47% Nasdaq 
Income Statement
